Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

5.86
BATS BZX Real-Time Price
As of 10:28am ET
 +0.05 / +0.86%
Today’s Change
4.45
Today|||52-Week Range
9.19
+9.53%
Year-to-Date
Benzinga's Option Alert Recap From March 21
Mar 21 / Benzinga - Paid Partner Content
Implied Volatility Surging for ZIOPHARM Oncology (ZIOP) Stock Options
Mar 20 / Zacks.com - Paid Partner Content
Don't Overlook Ziopharm Oncology
Mar 20 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close5.81
Today’s open5.82
Day’s range5.80 - 5.92
Volume3,322
Average volume (3 months)1,686,884
Market cap$769.1M
Dividend yield--
Data as of 10:28am ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)+56.67%
Earnings growth (next 5 years)--
Revenue growth (last year)+58.38%
P/E ratioNM
Price/Sales101.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ACRSAclaris Therapeutics...-0.25-0.84%
LCILannett Company Inc+0.45+2.16%
HRTXHeron Therapeutics I...-0.05-0.35%
----
Data as of 10:27am ET, 03/23/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$6.9M
Annual profit (last year)-$165.3M
Net profit margin-2,409.23%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Managing Director
Laurence James Neil Cooper
COO, Secretary, Chief Legal Officer &
Executive VP
Caesar J. Belbel
Corporate headquarters
Boston, Massachusetts

Forecasts


Search for Jobs